Arcion Therapeutics
About:
Arcion Therapeutics is a biotechnology company developing treatments for chronic pain.
Website: http://arciontherapeutics.com
Top Investors: InterWest Partners, CMEA Ventures
Description:
Arcion Therapeutics, Inc., a biotechnology company, focuses on the development of treatments for severe pain. It offers a pipeline of products for the treatment of painful diabetic neuropathy, post-herpetic neuralgia, and various forms of moderate and severe pain. The company was incorporated in 2007 and is based in Baltimore, Maryland.
Total Funding Amount:
$17M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Baltimore, Maryland, United States
Founded Date:
2007-01-01
Contact Email:
info(AT)arciontherapeutics.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2012-10-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai